Evaluates sensitivity of G-FET biosensors for cardiac troponin I detection, suggesting improvement in biosensor technology.
Graphene field-effect transistor (G-FET) biosensors require precise surface functionalization to achieve high sensitivity and stability. However, existing methods lack spatial control capabilities and may cause extensive damage to graphene's electrical properties. In this study, we introduce an atomic force microscopy (AFM)-based precision functionalization technique, enabling site-specific modification of graphene via redox reactions at a biased probe tip. This approach allows stable,localised immobilization of cTnI-specific aptamers, minimising graphene damage and yielding high-performance G-FET biosensors. The resulting sensor detects cardiac troponin I at concentrations as low as 0.01 pg/mL, exhibiting linear resistance response and strong selectivity in concentration gradient assays. This technology provides a scalable solution for constructing multiplexed biosensing within a single sensor.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: